The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Sun., Feb. 25, 8:09 PM

Slide #1. Tenax Therapeutics, Inc. (NASDAQ:TENX) 1 for 20 Reverse Split

Announced: 2/23/2018
Stock Split: 1 for 20
Record Date: 2/23/2018
Pay Date: 2/26/2018
TENX Optionable?: Yes

Tenax Therapeutics is a specialty pharmaceutical company. Co. focused on identifying, developing and commercializing products for the critical care market. Co. has a license to develop and commercialize pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion / 5ml vial, for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. In addition to its primary products, Co. has also developed Oxycyte, a perfluorocarbon-based oxygen carrier, its Dermacyte® line of topical cosmetic products, as well as Wundecyte™, a novel gel that is designed to be used as a wound-healing gel.
TENX Detailed Information Page & Split History »

Company Name: 
Tenax Therapeutics Inc
Website: 
www.tenaxthera.com
Sector: 
Biotechnology
Number of ETFs Holding TENX: 
1
Total Market Value Held by ETFs: 
$3333
Total Market Capitalization: 
$9.00M
% of Market Cap. Held by ETFs: 
0.04%

Open the TENX Page at The Online Investor (in a new window) »

List of Stock Splits in this Slideshow: Ticker Stock Split Announced Record Date Pay Date Optionable DES 3 for 1 10/25/2017 11/7/2017 11/9/2017 Yes EPS 3 for 1 10/25/2017 11/7/2017 11/9/2017 No EXT 3 for 1 10/25/2017 11/7/2017 11/9/2017 No MARA 4 for 1 10/27/2017 10/27/2017 10/30/2017 Yes CYTR 1 for 6 10/31/2017 10/31/2017 11/1/2017 Yes SPI 10 for 1 11/7/2017 11/6/2017 11/8/2017 No WLL 1 for 4 11/8/2017 11/8/2017 11/9/2017 Yes PATK 3 for 2 11/9/2017 12/8/2017 12/11/2017 Yes AMDA 1 for 12 11/10/2017 11/10/2017 11/10/2017 No MTW 1 for 4 11/17/2017 11/17/2017 11/20/2017 Yes NEOG 4 for 3 12/8/2017 12/18/2017 12/29/2017 Yes HEI 5 for 4 12/15/2017 1/17/2018 1/18/2018 Yes PMTS 1 for 5 12/19/2017 12/19/2017 12/20/2017 Yes UNG 1 for 4 12/22/2017 1/4/2017 1/5/2017 Yes RXII 1 for 10 1/5/2018 1/8/2018 1/8/2018 No OGEN 1 for 10 1/8/2018 1/19/2018 1/22/2018 No ARGS 1 for 20 1/18/2018 1/18/2018 1/19/2018 Yes HTBX 1 for 10 1/19/2018 1/19/2018 1/22/2018 No ZSAN 1 for 20 1/25/2018 1/25/2018 1/26/2018 No AVGR 1 for 40 1/30/2018 1/30/2018 1/30/2018 Yes INPX 30 for 1 2/6/2018 2/6/2018 2/6/2018 No NSPR 1 for 35 2/7/2018 2/7/2018 2/8/2018 No BPTH 1 for 10 2/9/2018 2/8/2018 2/9/2018 No FISV 2 for 1 2/22/2018 3/5/2018 3/19/2018 Yes TENX 1 for 20 2/23/2018 2/23/2018 2/26/2018 Yes
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
83rd percentile
(ranked higher than approx. 83% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2018, All Rights Reserved Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.